Human Sentrin-Specific Protease 2 (SENP2) Protein

Product Graph
234€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Sentrin-Specific Protease 2 (SENP2) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx692962
tested applications
SDS-PAGE

Description

Sentrin-Specific Protease 2 (SENP2) protein is a recombinant Human protein expressed in E. coli.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Sentrin-Specific Protease 2 (SENP2)
Host
E. coli
Assay Type
Activity: Not tested
Sequence Fragment: Asp363-Leu589
Tag: N-terminal 6 His tag
Origin
Human
Observed MW
26.8 kDa
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Size 1
10 µg
Size 2
50 µg
Form
Liquid
Tested Applications
SDS-PAGE
Buffer
50 mM HEPES, 5% Glycerol, pH 7.4.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Shelf Life: 6 months.
Dry Ice
No
UniProt ID
Q9HC62
Background
Protein SENP2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Endotoxin Level: < 1.0 EU per µg (LAL method).

Descripción

Related Products

Pr10074

Recombinant Human SENP2

Ver Producto
abx026733

SUMO Specific Peptidase 2 (SENP2) Antibody

SUMO is a small ubiquitin-like protein that can be covalently conjugated to other proteins. SENP2 is one of a group of enzymes that process newly synthesized SUMO1, SUMO2, and SUMO3 into the conjugatable mature forms and catalyze the deconjugation of these same SUMO proteins from their targeted substrates. SENP2 may also down-regulate CTNNB1 levels and thereby modulate the Wnt pathway.

Ver Producto
abx026741

SUMO Specific Peptidase 2 (SENP2) Antibody

SUMO is a small ubiquitin-like protein that can be covalently conjugated to other proteins. SENP2 is one of a group of enzymes that process newly synthesized SUMO1, SUMO2, and SUMO3 into the conjugatable mature forms and catalyze the deconjugation of these same SUMO proteins from their targeted substrates. SENP2 may also down-regulate CTNNB1 levels and thereby modulate the Wnt pathway.

Ver Producto